Connection

José Aguado to Vancomycin

Back to Details
This is a "connection" page, showing publications José Aguado has written about Vancomycin.
José Aguado
Connection Strength
0.446
Vancomycin
  1. Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain. Eur J Clin Microbiol Infect Dis. 2019 Jun; 38(6):1105-1111.
    View in: PubMed
    Score: 0.153
  2. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. Lancet Infect Dis. 2018 03; 18(3):296-307.
    View in: PubMed
    Score: 0.139
  3. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2017 07 01; 72(7):2102-2109.
    View in: PubMed
    Score: 0.135
  4. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. Enferm Infecc Microbiol Clin. 2009 Feb; 27(2):105-15.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.